Thomas Karn
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 83
-
- Ovarian cancer diagnosis and treatment 11
- Endometriosis Research and Treatment 5
- Co-authors
- Uwe Holtrich (70 shared papers)Achim Rody (53 shared papers)Manfred Kaufmann (22 shared papers)Lajos Pusztai (18 shared papers)Christine Solbach (23 shared papers)Andre Ahr (20 shared papers)Lars Hanker (25 shared papers)R. Gaetje (18 shared papers)
- Journals
- Breast Cancer Research and Treatment (13 papers)Clinical Cancer Research (12 papers)Annals of Oncology (11 papers)Journal of Cancer Research and Clinical Oncology (7 papers)European Journal of Cancer (6 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Thomas Karn
148 papers receiving 8.1k citations
Thomas Karn's Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 3.5k
- Oncology 2.1k
- Physiology 123
- Molecular Biology 1.5k
- Reproductive Medicine 220
Countries citing papers authored by Thomas Karn
This map shows the geographic impact of Thomas Karn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Karn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Karn more than expected).
Fields of papers citing papers by Thomas Karn
This network shows the impact of papers produced by Thomas Karn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Karn. The network helps show where Thomas Karn may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Karn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy Hit paper breakdown → | 2017 | 1689 |
| 2 | 2011 | 384 | |
| 3 | 2009 | 365 | |
| 4 | 2017 | 292 | |
| 5 | 2011 | 282 | |
| 6 | 2007 | 274 | |
| 7 | 1994 | 242 | |
| 8 | 2015 | 227 | |
| 9 | 2012 | 197 | |
| 10 | 2018 | 192 | |
| 11 | 1998 | 179 | |
| 12 | 2020 | 178 | |
| 13 | 2002 | 152 | |
| 14 | 2020 | 150 | |
| 15 | 2013 | 142 | |
| 16 | 2017 | 131 | |
| 17 | 2016 | 124 | |
| 18 | 2017 | 121 | |
| 19 | 2009 | 89 | |
| 20 | 2011 | 81 |
About Thomas Karn
Thomas Karn is a scholar working on Cancer Research, Reproductive Medicine, Oncology, Molecular Biology and Obstetrics and Gynecology, having authored 154 papers that have together received 8.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (83 papers), Cancer Immunotherapy and Biomarkers (11 papers), Ovarian cancer diagnosis and treatment (11 papers), Sphingolipid Metabolism and Signaling (8 papers), BRCA gene mutations in cancer (7 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Cells and Metastasis (5 papers) and Endometriosis Research and Treatment (5 papers). The work is most often cited by research in Cancer Research (3.5k citations), Oncology (2.1k citations), Physiology (123 citations), Molecular Biology (1.5k citations) and Reproductive Medicine (220 citations). Thomas Karn has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Uwe Holtrich, Achim Rody, Manfred Kaufmann, Lajos Pusztai, Christine Solbach, Andre Ahr, Lars Hanker, R. Gaetje, Klaus Strebhardt and Eugen Ruckhäberle. Their work appears in journals such as Breast Cancer Research and Treatment, Clinical Cancer Research, Annals of Oncology, Journal of Cancer Research and Clinical Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.